col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


38 Results       Page 1

 [1] 
American Chemical Society: Biochemistry
  original article Date Title Authors   All Authors
1 [GO] 2025―Mar―17 Design of Mimetic Antibodies Targeting the SARS-CoV-2 Spike Glycoprotein Based on the GB1 Domain: A Molecular Simulation and Experimental Study Anderson A. E Santo, Aline Reis, Anderson A. Pinheiro, Paulo I. da Costa, Gustavo T. Feliciano
2 [GO] 2025―Feb―05 A Cascade of Conformational Switches in SARS-CoV-2 Frameshifting: Coregulation by Upstream and Downstream Elements Samuel Lee, Shuting Yan, Abhishek Dey, Alain Laederach, Tamar Schlick
3 [GO] 2025―Jan―30 Structural and Mechanistic Insights into the Main Protease (Mpro) Dimer Interface Destabilization Inhibitor: Unveiling New Therapeutic Avenues against SARS-CoV-2 Ankur Singh, Kuldeep Jangid, Sanketkumar Nehul, Preeti Dhaka, Ruchi Rani, Akshay Pareek, et al. (+3)
4 [GO] 2025―Jan―10 A High-Throughput Screening Pipeline to Identify Methyltransferase and Exonuclease Inhibitors of SARS-CoV-2 NSP14 Quinlin Hanson, Xin Hu, Sourav Pal, Katlin Recabo, Lin Ye, Ivy Poon, et al. (+7)
5 [GO] 2024―Dec―30 How Polyproline Type II Conformation at P2 Residues Influences the Success of Proline-Based Peptidyl Inhibitors Against Coronavirus Main Protease Pathum Manjula Weerawarna
6 [GO] 2024―Dec―21 Disruption of Molecular Interactions between the G3BP1 Stress Granule Host Protein and the Nucleocapsid (NTD-N) Protein Impedes SARS-CoV-2 Virus Replication Preeti Dhaka, Ankur Singh, Sanketkumar Nehul, Shweta Choudhary, Prasan Kumar Panda, Gaurav Kumar Sharma, et al. (+2)
7 [GO] 2024―Nov―08 The Conformational Space of the SARS-CoV-2 Main Protease Active Site Loops Is Determined by Ligand Binding and Interprotomer Allostery Ethan Lee, Sarah Rauscher
8 [GO] 2024―Oct―21 High-Throughput Algorithmic Optimization of In Vitro Transcription for SARS-CoV-2 mRNA Vaccine Production Spencer E. McMinn, Danielle V. Miller, Daniel Yur, Kevin Stone, Yuting Xu, Ajit Vikram, et al. (+5)
9 [GO] 2024―May―10 Structure of the SARS-CoV-2 Frameshift Stimulatory Element with an Upstream Multibranch Loop Jake M. Peterson, Scott T. Becker, Collin A. O’Leary, Puneet Juneja, Yang Yang, Walter N. Moss
10 [GO] 2024―May―08 Characterization of nsp1 Binding to the Viral RNA Leader Sequence of Severe Acute Respiratory Syndrome Coronavirus Jonathan L. Cromer, Laurie F. Melton, Kaitlin M. Caughman, Anita Nag
11 [GO] 2024―Mar―08 RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer against SARS-CoV-2 Spike Protein Tatsuo Adachi, Shigetaka Nakamura, Akiya Michishita, Daiki Kawahara, Mizuki Yamamoto, Michiaki Hamada, Yoshikazu Nakamura
12 [GO] 2024―Feb―08 BRD4354 Is a Potent Covalent Inhibitor against the SARS-CoV-2 Main Protease Yan J. Sheng, Syuan-Ting A. Kuo, Tingyuan Yang, Hanyuan E. Zhang, David H. Russell, Xin Yan, et al. (+3)
13 [GO] 2024―Jan―13 Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus VP4, and HIV Vpu Julia A. Townsend, Oluwaseun Fapohunda, Zhihan Wang, Hieu Pham, Michael T. Taylor, Brian Kloss, et al. (+4)
14 [GO] 2023―Oct―20 SARS-CoV-2 Fusion Domain Provides Clues toward the Molecular Mechanism for Membrane Fusion Daniel Birtles, Jinwoo Lee
15 [GO] 2023―Jun―21 Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein Aakansha Nangarlia, Farah Fazloon Hassen, Gabriela Canziani, Praneeta Bandi, Choya Talukder, Fengwen Zhang, et al. (+8)
16 [GO] 2023―May―24 Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants Haihai Jiang, Yanru Zhou, Xiaofang Zou, Xiaohui Hu, Jie Wang, Pei Zeng, et al. (+4)
17 [GO] 2023―May―19 Biochemical and HDX Mass Spectral Characterization of the SARS-CoV-2 Nsp1 Protein Nawneet Mishra, Ravi Kant, Daisy W. Leung, Michael L. Gross, Gaya K. Amarasinghe
18 [GO] 2023―Jan―19 Mutation Effects on Structure and Dynamics: Adaptive Evolution of the SARS-CoV-2 Main Protease Elizabeth M. Diessner, Gemma R. Takahashi, Thomas J. Cross, Rachel W. Martin, Carter T. Butts
19 [GO] 2022―Dec―30 Computational Approaches for Development of Engineered Therapeutics against SARS-CoV-2 Aryaman Joshi, Timir Tripathi, Sumit K. Singh, Aditya K. Padhi
20 [GO] 2022―Nov―03 Predicting Antiviral Resistance Mutations in SARS-CoV-2 Main Protease with Computational and Experimental Screening Vishnu M. Sasi, Sven Ullrich, Jennifer Ton, Sarah E. Fry, Jason Johansen-Leete, Richard J. Payne, et al. (+2)
21 [GO] 2022―Oct―11 SARS-CoV-2 Envelope Protein Forms Clustered Pentamers in Lipid Bilayers Noah H. Somberg, Westley W. Wu, João Medeiros-Silva, Aurelio J. Dregni, Hyunil Jo, William F. DeGrado, Mei Hong
22 [GO] 2022―Sep―27 Energetics of Spike Protein Opening of SARS-CoV-1 and SARS-CoV-2 and Its Variants of Concern: Implications in Host Receptor Scanning and Transmission Jasdeep Singh, Shubham Vashishtha, Syed Asad Rahman, Nasreen Zafar Ehtesham, Anwar Alam, Bishwajit Kundu, Ulrich Dobrindt
23 [GO] 2022―Aug―31 Structural Insights into Binding of Remdesivir Triphosphate within the Replication-Transcription Complex of SARS-CoV-2 Jimin Wang, Yuanjun Shi, Krystle Reiss, Federica Maschietto, Elias Lolis, William H. Konigsberg, et al. (+2)
24 [GO] 2022―Aug―09 Recently Designed Multivalent Spike Binders Cannot Bind Multivalently─How Do They Achieve Enhanced Avidity to SARS-CoV-2? Harold P. Erickson, Lauren Corbin Goodman
25 [GO] 2022―May―05 Convergent Evolution of Multiple Mutations Improves the Viral Fitness of SARS-CoV-2 Variants by Balancing Positive and Negative Selection Vaibhav Upadhyay, Casey Patrick, Alexandra Lucas, Krishna M. G. Mallela
26 [GO] 2022―Feb―24 Insights into Binding of Single-Stranded Viral RNA Template to the Replication-Transcription Complex of SARS-CoV-2 for the Priming Reaction from Molecular Dynamics Simulations Jimin Wang, Yuanjun Shi, Krystle Reiss, Brandon Allen, Federica Maschietto, Elias Lolis, et al. (+3)
27 [GO] 2021―Sep―27 Identifying Distinct Structural Features of the SARS-CoV-2 Spike Protein Fusion Domain Essential for Membrane Interaction Daniel Birtles, Jinwoo Lee
28 [GO] 2021―Sep―10 Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode Gordon J. Lockbaum, Mina Henes, Jeong Min Lee, Jennifer Timm, Ellen A. Nalivaika, Paul R. Thompson, et al. (+2)
29 [GO] 2021―Jul―02 Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation Joel D. Allen, Himanshi Chawla, Firdaus Samsudin, Lorena Zuzic, Aishwary Tukaram Shivgan, Yasunori Watanabe, et al. (+21)
30 [GO] 2021―Jul―01 Protein Engineering in the Design of Protein-Protein Interactions: SARS-CoV-2 Inhibitors as a Test Case Jiří Zahradník, Gideon Schreiber
31 [GO] 2021―Jun―10 Mechanism of Inhibition of the Reproduction of SARS-CoV-2 and Ebola Viruses by Remdesivir Jimin Wang, Krystle Reiss, Yuanjun Shi, Elias Lolis, George P. Lisi, Victor S. Batista
32 [GO] 2021―Jun―03 “Just in Time”: The Role of Cryo-Electron Microscopy in Combating Recent Pandemics Joachim Frank
33 [GO] 2021―Apr―26 Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations Gennady M. Verkhivker, Steve Agajanian, Deniz Yazar Oztas, Grace Gupta
34 [GO] 2021―Feb―11 Enhanced Cholesterol-Dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to Its N-Terminal Counterpart Gourab Prasad Pattnaik, Surajit Bhattacharjya, Hirak Chakraborty
35 [GO] 2020―Nov―18 Exploring the Mechanism of Covalent Inhibition: Simulating the Binding Free Energy of α-Ketoamide Inhibitors of the Main Protease of SARS-CoV-2 Dibyendu Mondal, Arieh Warshel
36 [GO] 2020―Sep―15 Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease Thomas J. Cross, Gemma R. Takahashi, Elizabeth M. Diessner, Marquise G. Crosby, Vesta Farahmand, Shannon Zhuang, et al. (+2)
37 [GO] 2020―Jun―24 Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2 Nsp3 David N. Frick, Rajdeep S Virdi, Nemanja Vuksanovic, Narayan Dahal, Nicholas R. Silvaggi
38 [GO] 2020―Apr―15 Why are lopinavir and ritonavir effective against the newly emerged Coronavirus 2019?: Atomistic insights into the inhibitory mechanisms Bodee Nutho, Panupong Mahalapbutr, Kowit Hengphasatporn, Nawanwat Chainuwong Pattaranggoon, Nattapon Simanon, Yasuteru Shigeta, et al. (+2)
 [1] 

38 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec